PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Apr-2024 DocMorris launches approx. CHF 200 million Convertible Bonds due 2029 DocMorris AG
17-Apr-2024 Evotec SE to announce results for fiscal year 2023 on 24 April 2024 Evotec SE
17-Apr-2024 Annual General Meeting of Kuros Biosciences approves all resolutions Kuros Biosciences AG
17-Apr-2024 DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH Defence Therapeutics Inc.
17-Apr-2024 Evotec welcomes Aurélie Dalbiez as Chief People Officer Evotec SE
17-Apr-2024 Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG
17-Apr-2024 Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split Kinarus Therapeutics Holding AG
16-Apr-2024 CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines CureVac
16-Apr-2024 BRAIN Biotech AG takes next step to optimize group structure BRAIN Biotech AG
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK and SRG
16-Apr-2024 Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets Marinomed Biotech AG
16-Apr-2024 PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024 PharmaSGP Holding SE
16-Apr-2024 DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market DocMorris AG
15-Apr-2024 Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed Drägerwerk AG & Co. KGaA
15-Apr-2024 Strong financial foundation: DOUGLAS Group reduces net debt by 1 billion euros and increases financial flexibility Douglas AG
15-Apr-2024 Douglas AG announces satisfaction of transaction conditions Douglas AG
12-Apr-2024 Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast Formycon AG
12-Apr-2024 Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year Formycon AG
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA